Systemic metabolic switch and glycogen breakdown are required for effective resistance to <i>Streptococcus pneumoniae</i>. by Adam Bajgar (730380)

“…Loads, shown in logarithmic scale (values follow lognormal distribution), were compared with unpaired t-tests. (E) and (F) Knocking-down glycogen phosphorylase both specifically in the fat body (<i>ppl>GlyP[RNAi]</i>); purple in panel E) and in the whole flies (<i>Act>GlyP[RNAi]</i>; dark blue in panel F) significantly reduces survival (P<0.0001) when infected with <i>S</i>. …”

Transforming growth factor (TGF)-β1 induced a robust decrease in S-phase in non-cancer cell strains by Kimberly A Brown (26546)

The expression of 5-hmC was decreased in ESCC tissues and cell lines. by Xuejiao Shi (1684186)

Mutations decreasing complexity are more frequent than mutations increasing it. by Pascal F. Hagolani (10189866)

Old rat serum present higher levels of pro-inflammatory cytokine. by María Paz Saldías (4430032)

Decreased pDC abundance by 12 months of age after <i>E. cuniculi</i> infection. by Jason P. Gigley (218244)

<i>GLIS3</i> KD decreases SRp55 expression in INS-1E cells. by Tatiane C. Nogueira (185100)

Host population bottlenecks decrease microbiome diversity. by Michael Ørsted (5926028)

PowerPoint Slides for: Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy by Hwang J.H. (3300987)

“…Histologically, group 3 patients were correlated with severe interstitial fibrosis/tubular atrophy (p = 0.004), interstitial inflammation (p = 0.007), hyaline arteriolosclerosis (p = 0.001) and glomerular sclerosis (p < 0.001). A higher initial uPOSTN/Cr level was associated with a greater decline in eGFR during follow-up (p = 0.043 when initial eGFR ≥60; p = 0.025 when eGFR <60 ml/min/1.73 m2), and the renal outcomes with end-stage renal disease (ESRD; p = 0.003), ESRD and/or eGFR decrease of >30% (p = 0.033) and ESRD and/or eGFR decrease of >50% (p = 0.046) occurred significantly more in group 3. …”

Pancreatic cancer cell proliferation is decreased upon M344 treatment. by Shelby M. Knoche (13833807)

Resveratrol decreased acetylated RelA/p65. A. by Xiaoxia Zhu (301292)

Linear decrease of delta power (1.1–5.0 Hz) across the first three sleep cycles in the cortical, hippocampal and scalp recordings. by Fabio Moroni (34208)

cRGD treatment or microglial depletion augments the development of cerebral infarction and has no effect on blood-brain barrier (BBB) permeability after stroke. by Eric Yuhsiang Wang (17131666)

Subjects:

Original western blot images of Fig 4F–4I. by Eric Yuhsiang Wang (17131666)

Subjects:

Effects of A1AR expression on response to hypoxia at E9.5 and E12.5. by Daniela L. Buscariollo (140729)

“…<p>A: At E9.5, responses to hypoxia in A1AR −/− (n = 15) and A1AR +/− (n = 50) embryos were studied. …”

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

Effect estimates of primary outcomes endpoints among adolescents at 6- and 18-months follow-up receiving an SMS intervention compared with non-SMS group. by Anne Ahrendt Bjerregaard (7377500)

The illuminance‒speeding relationship across speed brackets. by Emanuel de Bellis (4732503)

P2X7 modulates migration and the epithelial-mesenchymal phenotype. by José David Nuñez-Ríos (18823719)

Decreased neutrophil and monocyte antigen expression in the paws of anti-S100A9-treated mice. by Annabelle Cesaro (112070)